Inhibition of ribonucleotide reductase subunit M2 enhances the radiosensitivity of metastatic pancreatic neuroendocrine tumor. Chow Z, Johnson J, Chauhan A, Jeong JC, et al. Cancer Lett 2024;596:216993.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Chow Z, Johnson J, Chauhan A, Jeong JC, et al. Inhibition of ribonucleotide reductase subunit M2 enhances the radiosensitivity of metastatic pancreatic neuroendocrine tumor. Cancer Lett 2024;596:216993.
PMID: 38801884